Tg Therapeutics (TGTX) Interest Coverage Ratio (2016 - 2025)
Historic Interest Coverage Ratio for Tg Therapeutics (TGTX) over the last 9 years, with Q3 2025 value amounting to 4.37.
- Tg Therapeutics' Interest Coverage Ratio rose 28062.2% to 4.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 3.77, marking a year-over-year increase of 1468225.17%. This contributed to the annual value of 1.75 for FY2024, which is 668.95% up from last year.
- Tg Therapeutics' Interest Coverage Ratio amounted to 4.37 in Q3 2025, which was up 28062.2% from 5.19 recorded in Q2 2025.
- Over the past 5 years, Tg Therapeutics' Interest Coverage Ratio peaked at 30.91 during Q3 2023, and registered a low of 86.14 during Q4 2021.
- Over the past 5 years, Tg Therapeutics' median Interest Coverage Ratio value was 12.32 (recorded in 2023), while the average stood at 17.6.
- In the last 5 years, Tg Therapeutics' Interest Coverage Ratio plummeted by 10922.1% in 2021 and then skyrocketed by 28062.2% in 2025.
- Over the past 5 years, Tg Therapeutics' Interest Coverage Ratio (Quarter) stood at 86.14 in 2021, then skyrocketed by 68.55% to 27.09 in 2022, then soared by 81.04% to 5.14 in 2023, then surged by 182.59% to 4.24 in 2024, then increased by 3.01% to 4.37 in 2025.
- Its Interest Coverage Ratio was 4.37 in Q3 2025, compared to 5.19 in Q2 2025 and 1.28 in Q1 2025.